These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1439151)

  • 21. Interleukin 6 response factor binds co-operatively at two adjacent sites in the promoter upstream region of the rat alpha 2-macroglobulin gene.
    Brechner T; Hocke G; Goel A; Fey GH
    Mol Biol Med; 1991 Apr; 8(2):267-85. PubMed ID: 1725449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin 6, but not ciliary neurotrophic factor or leukaemia inhibitory factor, is responsible for the acute phase response to turpentine-induced myositis.
    Kaibara A; Espat NJ; Auffenberg T; Abouhamze AS; Martin D; Kalra S; Moldawer LL
    Cytokine; 1998 Jun; 10(6):452-6. PubMed ID: 9632532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL6 signalling through IL6 receptor and receptor-associated signal transducer, gp130.
    Taga T
    Res Immunol; 1992 Sep; 143(7):737-9. PubMed ID: 1439146
    [No Abstract]   [Full Text] [Related]  

  • 24. IL-6 pathway in the liver: From physiopathology to therapy.
    Schmidt-Arras D; Rose-John S
    J Hepatol; 2016 Jun; 64(6):1403-15. PubMed ID: 26867490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuromodulation of acute-phase responses to interleukin-6 in guinea pigs.
    Blatteis CM; Quan N; Xin L; Ungar AL
    Brain Res Bull; 1990 Dec; 25(6):895-901. PubMed ID: 2126980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid pulmonary expression of acute-phase reactants after local lipopolysaccharide exposure in mice is followed by an interleukin-6 mediated systemic acute-phase response.
    Vernooy JH; Reynaert N; Wolfs TG; Cloots RH; Haegens A; de Vries B; Dentener MA; Buurman WA; Wouters EM
    Exp Lung Res; 2005; 31(9-10):855-71. PubMed ID: 16684717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ciliary neurotrophic factor is catabolic and shares with IL-6 the capacity to induce an acute phase response.
    Espat NJ; Auffenberg T; Rosenberg JJ; Rogy M; Martin D; Fang CH; Hasselgren PO; Copeland EM; Moldawer LL
    Am J Physiol; 1996 Jul; 271(1 Pt 2):R185-90. PubMed ID: 8760219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute-phase hepatocytes regulate liver sinusoidal cell mediator production.
    Bankey P; Prager M; Geldon D; Taylor S; McIntyre K
    Arch Surg; 1994 Nov; 129(11):1166-71. PubMed ID: 7526821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blocking interleukin-6 activity with chimeric anti-IL6 monoclonal antibodies in multiple myeloma: effects on soluble IL6 receptor and soluble gp130.
    Van Zaanen HC; Lokhorst HM; Aarden LA; Rensink HJ; Warnaar SO; Van Oers MH
    Leuk Lymphoma; 1998 Nov; 31(5-6):551-8. PubMed ID: 9922045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBP delta/NF-IL6 beta, are induced by IL-6 to promote acute phase gene transcription via different mechanisms.
    Ramji DP; Vitelli A; Tronche F; Cortese R; Ciliberto G
    Nucleic Acids Res; 1993 Jan; 21(2):289-94. PubMed ID: 7680115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human interleukin-6: safety issues of a pleiotropic growth factor.
    Kammüller ME
    Toxicology; 1995 Dec; 105(1):91-107. PubMed ID: 8638288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Similarity and synergy of trauma and sepsis: role of tumor necrosis factor-alpha and interleukin-6].
    Tang GJ
    Acta Anaesthesiol Sin; 1996 Sep; 34(3):141-9. PubMed ID: 9084538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL6 and the T-cell response.
    Houssiau F; Van Snick J
    Res Immunol; 1992 Sep; 143(7):740-3. PubMed ID: 1439147
    [No Abstract]   [Full Text] [Related]  

  • 34. Induction of an acute phase response in rats stimulates the expression of alpha 1(I) procollagen messenger ribonucleic acid in their livers. Possible role of interleukin-6.
    Greenwel P; Iraburu MJ; Reyes-Romero M; Meraz-Cruz N; Casado E; Solis-Herruzo JA; Rojkind M
    Lab Invest; 1995 Jan; 72(1):83-91. PubMed ID: 7837795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral blood cells from weight-losing cancer patients control the hepatic acute phase response by a primarily interleukin-6 dependent mechanism.
    O'Riordain MG; Falconer JS; Maingay J; Fearon KC; Ross JA
    Int J Oncol; 1999 Oct; 15(4):823-7. PubMed ID: 10493968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL6 and thrombocytopoiesis.
    Ishibashi T; Asano S
    Res Immunol; 1992 Sep; 143(7):752-4. PubMed ID: 1439150
    [No Abstract]   [Full Text] [Related]  

  • 37. Accessory factors involved in murine T cell activation. Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factor.
    Vink A; Uyttenhove C; Wauters P; Van Snick J
    Eur J Immunol; 1990 Jan; 20(1):1-6. PubMed ID: 2407536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi's sarcoma cells.
    Klouche M; Brockmeyer N; Knabbe C; Rose-John S
    AIDS; 2002 May; 16(8):F9-18. PubMed ID: 12004288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokines and the hepatic acute phase response.
    Moshage H
    J Pathol; 1997 Mar; 181(3):257-66. PubMed ID: 9155709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver nonparenchymal cells are stimulated to provide interleukin 6 for induction of the hepatic acute-phase response in endotoxemia but not in remote localized inflammation.
    Billiar TR; Curran RD; Williams DL; Kispert PH
    Arch Surg; 1992 Jan; 127(1):31-6; discussion 36-7. PubMed ID: 1734848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.